文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

床旁肺超声在呼吸机相关性肺炎诊断与严重程度评估中的应用价值

[Application value of lung ultrasound in the diagnosis and severity assessment of ventilator-associated pneumonia].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论床旁肺超声可早期发现VAP,联合PCT>0.5 μg/L串联试验将诊断特异性提至95.2%,LUSS与病情严重程度相关。

前瞻性观察研究纳入ICU中60例VAP患者与62例非VAP对照,比较肺超声(存在胸膜下小实变或组织样征且伴或不伴动态空气支气管征即为阳性)、VPLUS≥3、PCT>0.5 μg/L单独及联合诊断VAP的效能,并以胸部CT为金标准。肺超声阳性单独诊断的敏感度73.3%、特异度80.6%;与PCT>0.5 μg/L串联后特异度升至95.2%。LUSS与APACHE II、SOFA评分正相关(r=0.407、0.399),与PaO2/FiO2、PA-aDO2无关。提示肺超声可作为VAP早期诊断与疗效评估的有效方法。

要点

  • VAP组急诊手术比例、APACHE II、SOFA、气道脓性分泌物比例、机械通气时间、ICU住院时间及28天死亡率均高于非VAP组。
  • 肺超声阳性单独诊断VAP的敏感度73.3%、特异度80.6%(95%CI 0.685-0.842,P<0.05)。
  • 肺超声阳性联合PCT>0.5 μg/L串联试验,诊断VAP特异度升至95.2%,高于VPLUS≥3联合PCT的83.9%(P<0.05)。
  • LUSS与APACHE II评分(r=0.407,P=0.001)及SOFA评分(r=0.399,P=0.002)呈显著正相关。
  • LUSS与PaO2/FiO2(r=0.189,P=0.629)及PA-aDO2(r=-0.064,P=0.149)无相关性。

适用人群与场景

  • 2018年9月至2020年7月宁夏医科大学总医院ICU收治的机械通气患者,VAP组60例,非VAP对照组62例(性别、年龄及基础疾病与VAP组匹配)。

诊断标准与关键阈值

  • 肺超声阳性标准:存在胸膜下小实变或组织样征,伴或不伴动态空气支气管征。
  • VPLUS评分≥3分、PCT>0.5 μg/L作为诊断VAP的阳性阈值。
  • 以同期胸部CT阳性为诊断VAP的金标准。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 前瞻性观察研究,单中心,VAP组60例、非VAP组62例;VAP组急诊手术比例51.7% vs 33.9%(P=0.047),APACHE II 15.4±5.7 vs 13.4±3.4(P=0.021),SOFA 8.8±4.2 vs 6.3±3.3(P<0.001),气道脓性分泌物65.0% vs 41.9%(P=0.011),机械通气时间10.5(6.6,15.0)天 vs 4.3(3.0,6.0)天(P<0.001),ICU住院
  • 肺超声阳性诊断VAP的敏感度73.3%、特异度80.6%(95%CI 0.685-0.842,P<0.05);VPLUS≥3的敏感度75.0%、特异度58.1%(95%CI 0.574-0.748,P<0.05);PCT>0.5 μg/L的敏感度61.7%、特异度59.7%(95%CI 0.514-0.694,P<0.05)。
  • 肺超声阳性联合PCT>0.5 μg/L串联试验诊断VAP的特异度95.2%,VPLUS≥3联合PCT>0.5 μg/L串联试验特异度83.9%,前者高于后者(P<0.05)。
  • LUSS与APACHE II评分(r=0.407,P=0.001)和SOFA评分(r=0.399,P=0.002)呈显著正相关;与PaO2/FiO2(r=0.189,P=0.629)及PA-aDO2(r=-0.064,P=0.149)无相关性。

证据类型、等级与局限

  • 前瞻性观察性研究,单中心,样本量较小(VAP组60例、对照组62例),以胸部CT为金标准,未提及盲法及样本量计算,可能存在选择偏倚。

对床旁实践的改变

  • 对机械通气患者,床旁肺超声(胸膜下小实变或组织样征伴/不伴动态空气支气管征)可作为VAP的早期筛查工具;联合PCT>0.5 μg/L串联试验可提高诊断特异性至95.2%,减少假阳性。
  • LUSS可用于评估VAP患者病情严重程度,与APACHE II、SOFA评分正相关;但LUSS与氧合指标无关,不能替代氧合评估。
  • 原文未提及肺超声对VAP治疗决策(如抗生素调整)的影响,不能据此改变治疗流程。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the value of bedside lung ultrasound in the early diagnosis and severity assessment of ventilator-associated pneumonia (VAP).

METHODS: A prospective observational study was conducted in 60 patients with VAP (VAP group) and 62 patients without VAP (control group) who were admitted to department of intensive care unit of General Hospital of Ningxia Medical University from September 2018 to July 2020. The gender, age and underlying diseases of non-VAP group were matched with VAP group. The general clinical data such as gender, age, underlying diseases, department source of the patient, acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score were recorded. The body temperature, white blood cell count (WBC), procalcitonin (PCT), oxygenation index (PaO2/FiO2), alveolar artery oxygen differential pressure (PA-aDO2) were recorded. During mechanical ventilation, the patient's body temperature, WBC, sputum characteristics, and the change of the lung ultrasound were dynamically observed. With or without dynamic air bronchogram, lung ultrasound was considered to be positive as long as there were small subpleural consolidation or tissue-like sign. Ventilator-associated pneumonia lung ultrasound score (VPLUS) and lung ultrasound score (LUSS) were performed, and chest CT scan was completed on the same day. Use positive chest CT scan as the standard to evaluate the diagnostic efficacy of lung ultrasound, VPLUS score, and the combination of the two with PCT for VAP. LUSS was used to assess the severity of disease in patients with VAP. The correlation between LUSS and PaO2/FiO2, PA-aDO2, APACHE II score and SOFA score were analyzed.

RESULTS: (1) General information: compared with non-VAP group, VAP group had more emergency surgery patients [51.7% (31/60) vs. 33.9% (21/62), P = 0.047], APACHE II score and SOFA score were significantly higher (APACHE II score: 15.4±5.7 vs. 13.4±3.4, P = 0.021; SOFA score: 8.8±4.2 vs. 6.3±3.3, P < 0.001), body temperature tended to rise (centigrade: 38.3±0.8 vs. 38.0±0.9, P = 0.054), more patients had airway purulent secretions [65.0% (39/60) vs. 41.9% (26/62), P = 0.011], and mechanical ventilation time and length of ICU stay were longer [mechanical ventilation time (days): 10.5 (6.6, 15.0) vs. 4.3 (3.0, 6.0), P < 0.001; length of ICU stay (days): 14.8 (9.0, 18.0) vs. 6.0 (4.0, 9.1), P < 0.001], 28-day mortality rate was higher [31.7% (19/60) vs. 9.7% (6/62), P = 0.003]. (2) Diagnostic efficacy evaluation: when lung ultrasound was positive, VPLUS ≥ 3 and PCT > 0.5 μg/L were used separately for the diagnosis of VAP, the sensitivity was 73.3%, 75.0%, 61.7%, respectively; the specificity was 80.6%, 58.1% and 59.7%, respectively; the 95% confidence interval (95%CI) was 0.685-0.842, 0.574-0.748, 0.514-0.694, respectively,all P < 0.05, positive lung ultrasound had good sensitivity and specificity. When positive lung ultrasound or VPLUS ≥ 3 were combined with PCT > 0.5 μg/L for tandem test, the specificity of VAP diagnosis was increased to 95.2% and 83.9%, respectively; but the specificity of VAP diagnosis of positive lung ultrasound combined with PCT > 0.5 μg/L was higher than VPLUS ≥ 3 combined with PCT > 0.5 μg/L (95.2% vs. 83.9%, P < 0.05). (3) Correlation analysis: LUSS showed a significant positive correlation with APACHE II and SOFA score (r values were 0.407, 0.399, P values were 0.001, 0.002, respectively), LUSS had no relation with PaO2/FiO2 and PA-aDO2 (r values were 0.189, -0.064, P values were 0.629, 0.149, respectively).

CONCLUSIONS: Lung ultrasound can early detect VAP , and its diagnostic specificity is significantly improved when combined with PCT > 0.5 μg/L. LUSS is closely related to the severity of disease in VAP patients, therefore, lung ultrasound may be an effective method for early diagnosis and efficacy evaluation of VAP patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li J, Zhu J, Liu Q, et al. [Application value of lung ultrasound in the diagnosis and severity assessment of ventilator-associated pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296690. doi:10.3760/cma.j.cn121430-20200824-00589

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。